Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions
The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.
Format: | eBook |
---|---|
Language: | English |
Published: |
Nomos Verlagsgesellschaft mbH & Co. KG
2011
|
Series: | Munich Intellectual Property Law Center - MIPLC
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
Similar Items
-
Patentability Requirements for Nanotechnological Inventions An Approach from the European Patent Convention Perspective
Published: (2009) -
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
Published: (2014) -
Patenting Proteomics Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US law
Published: (2010) -
Second Generation Patents in Pharmaceutical Innovation
Published: (2014) -
Patents in the Food Sector A Retrospective with Special Emphasis on the TRIPs Agreement
Published: (2008)